These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19224430)

  • 1. Changes in insulin resistance and cardiovascular risk induced by PPARgamma activation have no impact on RBP4 plasma concentrations in nondiabetic patients.
    Pfützner A; Schöndorf T; Hanefeld M; Lübben G; Kann PH; Karagiannis E; Wilhelm B; Forst T
    Horm Metab Res; 2009 Mar; 41(3):202-6. PubMed ID: 19224430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visfatin: a putative biomarker for metabolic syndrome is not influenced by pioglitazone or simvastatin treatment in nondiabetic patients at cardiovascular risk -- results from the PIOSTAT study.
    Pfützner A; Hanefeld M; Lübben G; Weber MM; Karagiannis E; Köhler C; Hohberg C; Forst T
    Horm Metab Res; 2007 Oct; 39(10):764-8. PubMed ID: 17952841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rosiglitazone on visfatin and retinol-binding protein-4 plasma concentrations in HIV-positive patients.
    Haider DG; Schindler K; Mittermayer F; Müller M; Nowotny P; Rieger A; Luger A; Ludvik B; Wolzt M
    Clin Pharmacol Ther; 2007 Apr; 81(4):580-5. PubMed ID: 17235334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between changes in insulin sensitivity and associated cardiovascular disease risk factors in thiazolidinedione-treated, insulin-resistant, nondiabetic individuals: pioglitazone versus rosiglitazone.
    Abbasi F; Lima NK; Reaven GM
    Metabolism; 2009 Mar; 58(3):373-8. PubMed ID: 19217454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
    Tjokroprawiro A
    Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes.
    Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Numao T; Fukuda T; Shimada K; Kario K
    Hypertens Res; 2007 Jan; 30(1):23-30. PubMed ID: 17460368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioneer study: PPARgamma activation results in overall improvement of clinical and metabolic markers associated with insulin resistance independent of long-term glucose control.
    Pfützner A; Hohberg C; Lübben G; Pahler S; Pfützner AH; Kann P; Forst T
    Horm Metab Res; 2005 Aug; 37(8):510-5. PubMed ID: 16138265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral obesity is associated with the metabolic syndrome and elevated plasma retinol binding protein-4 level in obstructive sleep apnea syndrome.
    Makino S; Fujiwara M; Suzukawa K; Handa H; Fujie T; Ohtaka Y; Komatsu Y; Aoki Y; Maruyama H; Terada Y; Hashimoto K; Sugimoto T
    Horm Metab Res; 2009 Mar; 41(3):221-6. PubMed ID: 19003725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of the HOMA-B score for assessment of beta-cell functionality in interventional trials-results from the PIOglim study.
    Pfützner A; Derwahl M; Jacob S; Hohberg C; Blümner E; Lehmann U; Fuchs W; Forst T
    Diabetes Technol Ther; 2010 Aug; 12(8):599-604. PubMed ID: 20615100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum level of retinol-binding protein 4 in obese patients with insulin resistance and in patients with type 2 diabetes treated with metformin].
    Tajtáková M; Semanová Z; Ivancová G; Petrovicová J; Donicová V; Zemberová E
    Vnitr Lek; 2007 Sep; 53(9):960-3. PubMed ID: 18019665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum retinol-binding protein 4 is associated with insulin resistance in older women.
    Suh JB; Kim SM; Cho GJ; Choi KM; Han JH; Taek Geun H
    Metabolism; 2010 Jan; 59(1):118-22. PubMed ID: 19766271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of peroxisome proliferator-activated receptor-gamma activation with pioglitazone on plasma adipokines in nondiabetic patients with either hypercholesterolemia or hypertension.
    Barac A; Campia U; Matuskey LA; Lu L; Panza JA
    Am J Cardiol; 2008 Apr; 101(7):980-5. PubMed ID: 18359318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.
    Hanefeld M; Marx N; Pfützner A; Baurecht W; Lübben G; Karagiannis E; Stier U; Forst T
    J Am Coll Cardiol; 2007 Jan; 49(3):290-7. PubMed ID: 17239709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes.
    Cho YM; Youn BS; Lee H; Lee N; Min SS; Kwak SH; Lee HK; Park KS
    Diabetes Care; 2006 Nov; 29(11):2457-61. PubMed ID: 17065684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum gamma-glutamyltransferase levels are independently associated with insulin resistance in non-diabetic subjects.
    Shin JY; Chang SJ; Shin YG; Seo KS; Chung CH
    Diabetes Res Clin Pract; 2009 May; 84(2):152-7. PubMed ID: 19264371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk--the PIOSTAT Study.
    Forst T; Pfützner A; Lübben G; Weber M; Marx N; Karagiannis E; Koehler C; Baurecht W; Hohberg C; Hanefeld M
    Metabolism; 2007 Apr; 56(4):491-6. PubMed ID: 17379006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinol-binding protein 4 in polycystic ovary syndrome--association with steroid hormones and response to pioglitazone treatment.
    Aigner E; Bachofner N; Klein K; De Geyter C; Hohla F; Patsch W; Datz C
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1229-35. PubMed ID: 19158194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between serum retinol-binding protein 4 and small dense low-density lipoprotein cholesterol levels in young adult women.
    Usui S; Ichimura M; Ikeda S; Okamoto M
    Clin Chim Acta; 2009 Jan; 399(1-2):45-8. PubMed ID: 18782570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of pioglitazone on the liver: role of adiponectin.
    Gastaldelli A; Miyazaki Y; Mahankali A; Berria R; Pettiti M; Buzzigoli E; Ferrannini E; DeFronzo RA
    Diabetes Care; 2006 Oct; 29(10):2275-81. PubMed ID: 17003306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.